Irish startup Luminate is developing a helmet that applies pressure across the surface of the scalp to reduce hair loss ...

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in ...

In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of ...

Older adults with metastatic cancer living in Mexico experience a high time toxicity burden, spending about 21% of their days ...

A short course of chemotherapy given before conventional treatment significantly cuts the risk of dying from cervical cancer, ...

Chemo brain is a phenomenon where people with cancer notice that they can't think as clearly as they used to, according to ...

Ruined credit scores and big risks for bankruptcy: All part of the long-term financial fallout from the words "You have ...

The stock of small-cap biotech Jaguar Health Inc. rose 7% on Wednesday, after the company launched its gelclair treatment for ...

Based on our experience coming out of the pandemic, we are seeing that telehealth has the potential to quietly revolutionize ...

These breakthrough therapies have not only improved survival rates but also provided more targeted, less invasive options.

Astellas Pharma Ltd. today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization for PADCEV™ (enfortumab vedotin, an antibody-drug conjugate [ADC]) in ...

Although breast cancer is the most common non-skin cancer diagnosed in women, finding support during treatment and through survivorship can be incredibly challenging. An analysis of posts from breast ...